Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array

International Journal of Cancer

Volumn 82, Issue 6, 1999, Pages 868-874

  Backert, Steffen ^a   Gelos, Marcos ^a   Kobalz, Ursula ^a   Hanski, Marie Luise ^a   Böhm, Christian ^a   Mann, Benno ^a   Lövin, Nicole ^a   Gratchev, Alexei ^a   Mansmann, Ulrich ^a   Moyer, Mary Pat ^b   Riecken, Ernst Otto ^a   Hanski, Christoph ^a,c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; COMPLEMENTARY DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); PROTEIN P21; TRANSCRIPTION FACTOR;

ARTICLE; CANCER TISSUE; CARCINOMA CELL; CELL CYCLE; CELL FUNCTION; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLON CARCINOMA; COLON MUCOSA; CONTROLLED STUDY; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MUCINOUS CARCINOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA, MUCINOUS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; COLON; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA REPAIR; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; NUCLEAR PROTEINS; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPPRESSION, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032817385     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990909)82:6<868::AID-IJC16>3.0.CO;2-W     Document Type: Article

References (40)

1. ARBER, N., HIBSHOOSH, H., MOSS, S.F., SUTTER, T., ZHANG, Y., BEGG, M., WANG, S., WEINSTEIN, I.B. and HOLT, P.R., Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Castroenterology, 110, 669-674 (1996).
2. 2 arrest after DNA damage. Science, 282, 1497-1501 (1998).
3. DIATCHENKO, L., LAU, Y.F.C., CAMPBELL, A.P., CHENCHIK, A., MOQADAM, F., HUANG, B., LUKYANOV, S., LUKYANOV, K., GURSKAYA, N., SVERDLOV, E.D. and SIEBERT, P.D., Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. nat. Acad. Sci. (Wash.), 93, 6025-6030 (1996).
4. DUGUID, J.R. and DINAUER, M.C., Library subtraction of in vitro cDNA libraries to identify differentially expressed genes in Scrapie infection. Nucleic Acids Res., 18, 2789-2792 (1990).
5. EASTHAM, J.A., HALL, S.J., SEHGAL, J., WANG, J., TIMME, T.L., YANG, G., CONNELL, CROWLEY, L., ELLEDGE, S.J., ZHANG, W.W., HARPER, J.W. and THOMPSON, T.C., In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res., 55, 5151-5155 (1995).
6. GALAKTIONOV, K., LEE, A.K., ECKSTEIN, J., DRAETTA, G., MECKLER, J., LODA, M. and BEACH, D., CDC25 phosphatases as potential human oncogenes. Science, 269, 1575-1577 (1995).
7. GELOS, M., BACKERT, S., KLUSSMANN, E., GRATCHEV, A., KOBALZ, U., MANN, B., MOYER, M.P., BOHM, C., RIECKEN, E.O. and HANSKI, C., Detection of differential gene expression in colorectal cancer cell lines: comparison of three methods. J. mol. Med., 76, B13 (1998).
8. GERGEN, J.P., STEN, R.H. and WENSINK, P.C., Filter replicas and permanent collections of recombinant DNA plasmids. Nucleic Acids Res., 7, 2115-2136 (1979).
9. GONZALEZ-ZULUETA, M., BENDER, C.M., YANG, A.S., NGUYEN, T., BEART, R. W., VAN TORNOUT, J.M. and JONES, P.A., Methylation of the 5′CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535 (1995).
10. HANSKI, C., Is mucinous carcinoma of the colorectum a distinct genetic entity? Brit. J. Cancer, 72, 1350-1356 (1995).
11. HANSKI, C., RIEDE, E., GRATCHEV, A., FOSS, H.D., STEIN, H. and RIECKEN, E.O., MUC2 Gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. Lab. Invest., 77, 685-695 (1997).
12. HANSKI, C., TIECKE, F., HUMMEL, M., HANSKI M.-L., OGOREK, D., ROLFS, A., SCHMITT-GRAFF, A., STEIN, H. and RIECKEN, E.-O., Low frequency of p53 gene mutation and protein expression in mucinous colorectal carcinomas. Cancer Lett., 103, 163-170 (1996).
13. HOEIJMAKERS, J.H., EGLY, J.M. and VERMEULEN, W., TFIIH: a key component in multiple DNA transactions. Curr. Opin. Genet. Develop., 6, 26-33 (1996).
14. JUNG, J.M., BRUNER, J.M., RUAN, S., LANGFORD, L.A., KYRITSIS, A.P., KOBAYASHI, T., LEVIN, V.A. and ZHANG, W., Increased levels of p21 WAF1/ CIP1 in human brain tumors. Oncogene, 11, 2021-2028 (1995).
15. KANE, M.F., LODA, M., GAIDA, G.M., LIPMAN, J., MISHRA, R., GOLDMAN, H., JESSUP, J.M. and KOLODNER, R., Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumours and mismatch repair-defective human tumor cell lines. Cancer Res., 57, 808-811 (1997).
16. KAPITANOVIC, S., RADOSEVIC, S., KAPITANOVIC, M., ANDELINOVIC, S., FERENCIC, Z., PAVELIC, K. and SPAVENTI, R., The expression of p185 (HER-2/neu) correlates with the stage of disease and survival in colorectal cancer. Gastroenterology, 112, 1103-1113 (1997).
17. KLIMPFINGER, M., ZISSER, G., RUHRI, C., PUTZ, B., STEINDORFER, P. and HOFLER, H., Expression of c-myc and c-fos mRNA in colorectal carcinoma in man. Virchows Arch. B Cell Pathol. Incl. mol. Pathol., 59, 165-171 (1990).
18. LIANG, P. and PARDEE, A.B., Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967-971 (1992).
19. MANN, B., GELOS, M., SIEDOW, A., HANSKI, M.-L., GRATCHEV, A., ILYAS, M., BODMER, W., MOYER, M.P., RIECKEN, E.O., BUHR, H.J. and HANSKI, C., Target genes of the β-catenin-T-cell-enhancer factor/lymphoid-enhancer factor signaling pathway in human colorectal carcinoma. Proc. nat. Acad. Sci. (Wash.), 96, 1603-1608 (1999).
20. MATSUSHITA, K., KOBAYASHI, S., KATO, M., ITOH, Y., OKUYAMA, K., SAKIYAMA, S. and ISONO, K., Reduced messenger RNA expression levels of p21CIP1 in human colorectal carcinoma tissues and its association with p55 gene mutation. Int. J. Cancer, 69, 259-264 (1996).
21. MINDERMAN, H., VANHOEFER, U., TOTH, K., MINDERMAN, M.D. and RUSTUM, Y.M., A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance. Cancer, 78, 2427-2436 (1996).
22. cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science, 257, 1955-1957 (1992).
23. SAGER, R., Expression genetics: shifting the focus from DNA to RNA. Proc. nat. Acad. Sci. (Wash.), 96, 952-955 (1997).
24. SCHENA, M., SHALON, D., HELLER, R., CHAI, R., BROWN, P.O. and DAVIS, R.W., Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. nat. Acad. Sci. (Wash.), 93, 10614-10619 (1996).
25. SAMBROOK, J., FRITSCH, E.F., MANIATIS, T., Cold Spring Laboratory Press. A laboratory manual (1989).
26. SHERR, C.J., Cancer cell cycles. Science, 274, 1672-1677 (1996).
27. SHIOHARA, M., EL-DEIRY, W.S., WADA, M., NAKAMAKI, T., TAKEUCHI, S., YANG, R., CHEN, D.-L., VOGELSTEIN, B. and KOEFFLER, H.P., Absence of WAF1 mutations in a variety of human malignancies. Blood, 11, 3781-3784 (1994).
28. WAF1/Cipl protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers. Clin. Cancer Res., 4, 1251-1261 (1998).
29. STAUFFER, J.S., MANZANO, L.A., BALCH, G.C., MERRIMAN, R.L., TANZER, L.R. and MOYER, M.P., Development and characterization of normal colonic epithelial cell lines derived from normal mucosa of patients with colon cancer. Amer. J. Surg., 169, 190-196 (1995).
30. TSUSHIMA, H., KAWATA, S., TAMURA, S., ITO, N., SHIRAI, Y., KISO, S., IMAI, Y., SHIMOMUKAI, H., NOMURA, Y., MATSUDA, Y. and MATSUZAWA, Y., High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology, 110, 375-382 (1996).
31. VELCULESCU, V.E., ZHANG, B., VOGELSTEIN, B. and KINZLER, K.W., Serial analysis of gene expression. Science, 270, 484-487 (1995).
32. VERSTUNEN, C.P., ARENDS, J.W., MOERKERKA, P.T., GERAEDTS, J.P., SEKIKAWA, K., UITENDAAL, M.P. and BOSMAN, F.T., The establishment and characterization of two new cell lines derived from a single human colonic adenocarcinoma. Virchows Arch. B Cell Pathol Incl. mol. Pathol., 53, 191-197 (1987).
33. VIDER, B.Z., ZIMBER, A., CHASTRE, E., PREVOT, S., GESPACH, C., ESTLEIN, D., WOLLOCH, Y., TRONICK, S.R., GAZIT, A. and YANIV, A., Evidence for the involvement of the Wnt 2 gene in human colorectal cancer. Oncogene, 12, 153-158 (1996).
34. VIEL, A., MAESTRO, R., TOFFOLI, G., GRION, G. and BOIOCCHI, M., c-myc overexpression is a tumour-specific phenomenon in a subset of human colorectal carcinomas. J. Cancer Res. Clin. Oncol., 116, 288-294 (1990).
35. WANG, A., YOSHIMI, N., INO, N., TANAKA, T. and MORI, H., WAF1 expression and p53 mutations in human colorectal cancers. J. Cancer Res. clin. Oncol., 123, 118-123 (1997).
36. WATANABE, N., BROOME, M. and HUNTER, T., Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J., 14, 1878-1891 (1995).
37. WEINER, T.M., LIU, E.T., CRAVEN, R.J. and CANCE, W.G., Expression of focal adhesion kinase gene and invasive cancer. Lancet, 342, 1024-1025 (1993).
38. WOODMAN, A.C., SUGIYAMA, M., YOSHIDA, K., SUGINO, T., BORGYA, A., GOODISON, S., MATSUMARA, Y. and TARIN, D., Analysis of anomalous CD44 gene expression in human breast, bladder and colon cancer and correlation of observed mRNA and protein isoforms. Amer. J. Pathol., 149, 1519-1530 (1996).
39. WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity. Pathol. Int., 47, 470-477 (1997).
40. ZHANG, L., ZHOU, W., VELCULESCU, V.E., KERN, S., HRUBAN, R.H., HAMILTON, S.R., VOGELSTEIN, B. and KINZLER, K.W., Gene expression profiles in normal and cancer cells. Science, 276, 1268-1272 (1997).